Loading…
Efficient Expansion of Human Granzyme B-Expressing B Cells with Potent Regulatory Properties
Granzyme B-expressing B cells have been shown to be an important regulatory B cell subset in humans. However, it is unclear which subpopulations of B cells express GZMB under normal conditions and which protocols effectively induce ex vivo expansion of GZMB B cells. We found that in the peripheral b...
Saved in:
Published in: | The Journal of immunology (1950) 2020-11, Vol.205 (9), p.2391-2401 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Granzyme B-expressing B cells have been shown to be an important regulatory B cell subset in humans. However, it is unclear which subpopulations of B cells express GZMB under normal conditions and which protocols effectively induce ex vivo expansion of GZMB
B cells. We found that in the peripheral blood of normal individuals, plasmablasts were the major B cell subpopulation that expressed GZMB. However, when using an in vitro plasmablast differentiation protocol, we obtained only 2% GZMB
B cells. Nevertheless, using an expansion mixture containing IL-21, anti-BCR, CpG oligodeoxynucleotide, CD40L, and IL-2, we were able to obtain more than 90% GZMB
B cells after 3 d culture. GZMB
B cells obtained through this protocol suppressed the proliferation of autologous and allogenic CD4
CD25
effector T cells. The suppressive effect of GZMB
B cells was partially GZMB dependent and totally contact dependent but was not associated with an increase in effector T cell apoptosis or uptake of GZMB by effector T cells. Interestingly, we showed that GZMB produced by B cells promoted GZMB
B cell proliferation in ERK1/2-dependent manner, facilitating GZMB
B cell expansion. However, GZMB
B cells tended to undergo apoptosis after prolonged stimulation, which may be considered a negative feedback mechanism to limit their uncontrolled expansion. Finally, we found that expanded GZMB
B cells exhibited a regulatory phenotype and were enriched in CD307b
, CD258
CD72
, and CD21loPD-1
B cell subpopulations. Our study, to our knowledge, provides new insight into biology of GZMB
B cells and an efficient method to expand GZMB
B cells for future cell therapy applications. |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.2000335 |